<

 
Data updated 2025-05-02 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date08743213.4 (espacenet)  (Federated)  (European Patent Register), 20080422
Patent/reg. no. and dateDK/EP 2157967, 20130116
Publication date20100303
Priority no. and dateUS 926005 P, 20070423, US 72202 P, 20080328
EP pub. no. and date EP 2157967 20100303
Effective date
Applicant/ownerIntarcia Therapeutics, Inc, 24650 Industrial Boulevard
Hayward CA 94545, US
Applicant ref. no.157257
InventorYANG, Bing, 802 Kraken Lane
Redwood City, CA 94065, US,
ALESSI, Thomas, R., 25679 Paul Court
Hayward, CA 94541, US,
MERCER, Ryan, D., 7594 Carlow Way
Dublin, CA 94568, US,
ROHLOFF, Catherine, M., 1994 Deodara Drive
Los Altos, CA 94024, US
RepresentativeAWA Denmark A/S, Strandgade 56, 1401 København K, DK
Opponent
IPC ClassA61K 38/26 (2006.01) , A61K 47/14 (2006.01) , A61K 9/00 (2006.01) , A61K 9/10 (2006.01) , A61K 9/16 (2006.01) , A61K 9/70 (2006.01) , C07K 14/605 (2006.01) , C07K 7/06 (2006.01) 
TitleSuspensionsformuleringer af insulinotropiske peptider og anvendelser deraf
Int. application no.US2008005235
Int. publication no.WO2008133908
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact